Nonalcoholic fatty liver disease is increasingly recognized as a major global health problem.
Intertwined with diabetes, metabolic syndrome, and obesity, nonalcoholic fatty liver disease …

The most common cause of death in patients with nonalcoholic fatty liver disease (NAFLD) is
coronary artery disease (CAD), not chronic liver disease. Fatty liver increases cardiovascular …

Nonalcoholic fatty liver disease (NAFLD) is a global epidemic.(1) Worldwide, 1 in 4 people
have NAFLD.(2) Further, increasing in parallel with the rising prevalence of obesity and …

Background and aims Non-alcoholic fatty liver disease (NAFLD) is a multisystem disease
closely linked to cardiovascular disease (CVD). This study aims to investigate the …

Non-alcoholic fatty liver disease (NAFLD) is a common diagnosis and is increasing in
prevalence worldwide. NAFLD is usually asymptomatic at presentation; progression of the …

Nonalcoholic fatty liver disease (NAFLD) is a common form of primary fatty liver almost
universally associated with metabolic risk factors. Histologically, NAFLD is categorized as …

Non-alcoholic fatty liver disease (NAFLD) is a serious clinicopathological condition that is
recognized as the most frequent chronic liver disease, affecting 14–30% of the world's …

Over the last 20 years, chronic lifestyle-related diseases such as visceral obesity, type 2
diabetes mellitus (T2DM), and non-alcoholic fatty liver disease (NAFLD) have exacerbated …

The prevalence of non-alcoholic fatty liver disease (NAFLD), one of the most common liver
diseases, is rising. About 25% of adults worldwide are probably affected by NAFLD. Insulin …

Nonalcoholic fatty liver disease (NAFLD) is defined as the presence of hepatic fat
accumulation after the exclusion of other causes of hepatic steatosis, including other causes …